DENTSPLY SIRONA (NASDAQ:XRAY) Downgraded by StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Friday.

XRAY has been the topic of a number of other research reports. Piper Sandler reaffirmed a “neutral” rating and set a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday. SVB Leerink initiated coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective on the stock. Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday. Finally, Barrington Research decreased their price objective on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a report on Friday. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $36.90.

DENTSPLY SIRONA Trading Down 0.3 %

NASDAQ XRAY opened at $28.29 on Friday. The stock has a market cap of $5.87 billion, a P/E ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a fifty-two week low of $26.27 and a fifty-two week high of $41.65. The stock has a 50 day simple moving average of $32.13 and a two-hundred day simple moving average of $32.71. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.95 and a current ratio of 1.43.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm’s revenue was down 2.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.39 earnings per share. On average, analysts forecast that DENTSPLY SIRONA will post 2.05 earnings per share for the current year.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently bought and sold shares of XRAY. VisionPoint Advisory Group LLC increased its position in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 395 shares in the last quarter. Principal Securities Inc. bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth $26,000. Headlands Technologies LLC purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $30,000. Parkside Financial Bank & Trust lifted its holdings in shares of DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at $47,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.